Lv3
290 积分 2025-05-15 加入
Trispecific antibodies in cancer therapy: Mechanisms, clinical progress and future directions
1天前
待确认
Back on the scene: Advances and challenges in CD3-related drugs in tumor therapy
16天前
已完结
The BAFF/APRIL system in SLE pathogenesis
1个月前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
1个月前
已完结
Naturally occurring antibodies devoid of light chains
1个月前
已完结
The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment
3个月前
已完结
Organizing structural principles of the IL-17 ligand–receptor axis
4个月前
已完结
Optimization of a novel 2+2 BCMA x CD3 bispecific antibody for minimized cytokine release and potent efficacy
5个月前
已完结
CD19, from bench to bedside
5个月前
已完结
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
5个月前
已完结
皖公网安备34019202002308
